Invokana 300 mg, Filmtabletten - 30 Tablette(n) Swissmedic Key 62956006 PP Registration Holder Janssen-Cilag AG Name Invokana 300 mg, Filmtabletten Date of registration 29.01.2014 Introduction of Sequence 29.01.2014 ATC-Classification Canagliflozin (A10BK02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 30 Tablette(n) Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 53.88 Limitation Yes Limitation text
Deductible 10 % Consumer price 75.00 Feedback FB Daily cost GTIN 7680629560067 Medication Code Synthetika Pharmacode 5900926 Disponibility
Composition canagliflozinum 300 mg ut canagliflozinum hemihydricum, cellulosum microcristallinum, lactosum 117.78 mg, carmellosum natricum conexum corresp. natrium 2.52 mg, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Canagliflozinum 300 mg
BAG: Active Agent Dose Canagliflozinum 300 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hydroxypropylcellulosum Lactosum 117.78 mg Macrogol 3350 Magnesii Stearas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 06.12.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
